Oxaliplatin in Rectal Cancer
* Phase I: To determine the maximum tolerated dose, and recommended dose of the proposed doses of oxaliplatin in this study
* Phase II: To determine the treatment efficacy according to response rates from phase I.
Rectal Neoplasms
DRUG: Oxaliplatin
Phase I : Maximum Tolerated Dose & Recommended Dose, Days 1, 15, 29|Phase II : Response and resectability rate., 6 cycles in 6 months
* Phase I: To determine the maximum tolerated dose, and recommended dose of the proposed doses of oxaliplatin in this study
* Phase II: To determine the treatment efficacy according to response rates from phase I.